Magnetic Resonance System G-scan Brio (Part Number /Model No.101002000)
FDA Device Recall #Z-2124-2016 — Class II — June 6, 2016
Recall Summary
| Recall Number | Z-2124-2016 |
| Classification | Class II — Moderate risk |
| Date Initiated | June 6, 2016 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Esaote S.p.A. |
| Location | Firenze, N/A |
| Product Type | Devices |
| Quantity | 11 USA; 29 OUS |
Product Description
Magnetic Resonance System G-scan Brio (Part Number /Model No.101002000)
Reason for Recall
The device is being recalled because dynamic loading forces from larger patients can fracture the extremity portion of the patient table. Additionally, a weight limit is added to the patient seat for weight-bearing examinations.
Distribution Pattern
Domestic: FL, TX, OH, MN, NV; Foreign: No customers in Canada; No VA/DOD.
Lot / Code Information
Item No., Unit Description and Serial No.s: 101002000, UNIT, G-SCAN BRIO, 05202; 101002000, UNIT, G-SCAN BRIO, 05203; 101002000, UNIT, G-SCAN BRIO 2.1A; 05205; 101002000, UNIT, G-SCAN BRIO 2.1A, 05207; 101002000 UNIT, G-SCAN BRIO 2.1A, 05208; 101002000 UNIT, G-SCAN BRIO 2.1A, 05209; 101002000 UNIT, G-SCAN BRIO 2.1A, 05210; 101002000 UNIT, G-SCAN BRIO 2.1A, 05211; 101002000 UNIT, G-SCAN BRIO 2.1A, 05305; 101002000 UNIT, G-SCAN BRIO 2.1A, 05308
Other Recalls from Esaote S.p.A.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1490-2026 | Class II | Esaote Endocavity ultrasonic probe, Model E 3-1... | Mar 14, 2025 |
| Z-0205-2019 | Class II | MyLab Gamma, Model 7410 | Jun 11, 2018 |
| Z-0204-2019 | Class II | MyLab Alpha, Model 7400 | Jun 11, 2018 |
| Z-0206-2019 | Class II | MyLab Seven, Model 6400 | Jun 11, 2018 |
| Z-1138-2018 | Class II | MyLab Ultrasound System; Models 6100, 6150, 620... | Jan 3, 2018 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.